Background and Purpose-To investigate whether molecular markers of inflammation and endothelial injury are associated with early growth of intracerebral hemorrhage (ICH). Methods-In a multicenter prospective study, we determined concentrations of interleukin-6 (IL-6), tumor necrosis factor-␣ (TNF-␣), matrix metalloproteinase-9 (MMP-9), and cellular fibronectin (c-Fn) in blood samples obtained on admission from 183 patients with primary hemispheric ICH of Ͻ12 hours' duration. Patients had a neurological evaluation and a computed tomography (CT) scan performed at baseline and at 48Ϯ6 hours. Early growth of the ICH was defined as a volume increase Ͼ33% between the 2 CT examinations for ICH with a baseline volume Ͻ20 mL and Ͼ10% for ICH Ն20 mL. Clinical, radiological, and biochemical predictive factors of ICH enlargement were analyzed by logistic regression analysis. Results-Fifty-four (29.5%) patients showed a relevant early growth of ICH. High leukocyte count and fibrinogen levels, low platelet count, and intraventricular bleeding were associated with early ICH growth in bivariate analyses. 
I
ntracerebral hemorrhage (ICH) causes a 35% to 50% 30-day mortality. Half of this mortality occurs within the first 2 days as a result of brain herniation, mainly caused by the continued bleeding that provokes an enlargement of the hematoma during the first 24 hours. 1 Early hematoma growth (EHG) has been associated with early neurological worsening and poor outcome, but no clinical or radiological predictive factors have been identified and the pathogenesis remains unclear. 2, 3 A better knowledge of the molecular mechanisms involved in the early growth and perilesional brain injury of ICH may help to find a more appropriate treatment in the acute phase.
EHG has been related to multifocal bleeding in the periphery of the clot caused by the rupture of arterioles and venules in the perilesional low-flow zone. 4 Secondary brain injury has been attributed to ischemic damage and particularly to the toxic effects of thrombin generation by the clot. 5 In experimental ICH, thrombin activates the inflammatory cascade and the expression of matrix metalloproteinases (MMPs), causing the breakdown of the blood-brain barrier and edema formation. 6 -8 In this context, high serum concentrations of cytokines and MMP-9 have been associated with a large volume of peripheral hypodensity in human ICH. 9, 10 MMPs are able to degrade the basal membrane components, such as cellular fibronectin (c-Fn), a glycoprotein especially important for the adhesion of platelets to fibrin, a function necessary for the blockade of bleeding. 11 Increased levels of MMP-9 and c-Fn have been found in the blood of patients with hemorrhagic transformation after cerebral infarction. 12,13 Therefore, we hypothesize that the activation of the inflammatory cascade, MMP-9 overexpression, and c-Fn degradation may occur after ICH in the tissue around the hematoma, and that these molecules might be involved in vessel rupture and hematoma growth. The aim of this study was to investigate whether high concentrations of cytokines, MMP-9, and c-Fn in peripheral blood are associated with the early growth of ICH.
Subjects and Methods
This is a secondary analysis of a prospective, multicenter study performed to identify predictors of early neurological deterioration in 266 patients with primary hemispheric ICH admitted within 12 hours from the onset of symptoms. 14 Exclusion criteria were age younger than 18, surgical treatment on admission, coma with expected death within 48 hours, and hemorrhage secondary to brain tumor, trauma, drug abuse, coagulation disorders, anticoagulant therapy, or vascular malformation. For the purpose of this study we also excluded patients without stored frozen blood samples obtained on admission (nϭ74) and those in whom computed tomography (CT) scan was not available at 48 hours (nϭ4). The study was approved by the institutional review boards of all participating institutions and informed consent was obtained from the patients or their relatives.
On arrival to the emergency department, blood pressure and body temperature were recorded and blood samples were taken. Each patient underwent a baseline head CT scan and a Canadian Stroke Scale (CSS) 15 evaluation by an experienced neurologist. Patients were admitted to a neurological ward or an acute stroke unit and were treated by a specialized stroke team and nursing staff following established guidelines. 16 Antihypertensive treatment with intravenous labetalol or captopril was administered in case of systolic blood pressure Ͼ185 mm Hg or diastolic blood pressure Ͼ105 mm Hg. Low-dose subcutaneous heparin was used for the prevention of deep vein thrombosis and pulmonary thromboembolism. None of the patients was part of a therapeutic clinical trial.
A second CT scan was performed at 48Ϯ6 hours. The evaluation of all CT scans was performed at the coordinating center by a single investigator who was blinded to the clinical and biochemical data. Lesion volumes were calculated on the radiographic plate using the formula 0.5 ϫ a ϫ b ϫ c (where a is the maximal longitudinal diameter, b is the maximal transverse diameter, and c is the number of 10-mm slices containing hemorrhage). The volume of the ICH plus that of the zone of peripheral hypodensity was determined using the same volumetric method described; the absolute volume of the hypodensity was calculated by subtracting the volume of the ICH from that of the total lesion (ICH plus peripheral hypodensity). According to a previous report, relevant EHG was defined as a volume increase Ͼ33% between the 2 CT for those ICHs with a baseline volume Ͻ20 mL, and a volume increase Ͼ10% for those hemorrhages with a baseline volume Ն20 mL. 14 Secondary analyses were performed using the Ͼ33% growth definition for all patients in a way to be compared with another prospective study in which this definition was used. 2 The ICH topography was classified as lobar when it affected predominantly the cortical or subcortical white matter of the cerebral lobes, or as deep when it was limited to the internal capsule, the basal ganglia, or the thalamus. The presence of intraventricular extension of the hematoma, leukoaraiosis, and mass effect was also recorded.
Early neurological deterioration (END) was diagnosed when the CSS score decreased 1 or more points between admission and 48 hours after admission. This difference represents the change with the highest sensitivity, retaining good specificity. 17 Patients who died within the first 48 hours were classified in the END group if they had progressed during the observations that followed after inclusion. Functional outcome was evaluated by the modified Rankin scale at 90 days. Patients with a modified Rankin scale score Ͼ2 were classified in the poor outcome category.
Laboratory Determinations
Blood samples were collected on admission in tubes with potassium edetate, centrifuged at 3000g for 5 minutes, and immediately frozen and stored at Ϫ80°. IL-6 and tumor necrosis factor-␣ (TNF- Potential predictors of EHG in the bivariate analyses (PϽ0.05) were tabulated and were then analyzed by logistic regression (probability of entry PϽ0.05). In a further logistic model, we investigated whether predictors of EHG were also independently associated with END, poor functional outcome, and mortality at 3 months. We tested the linearity of the explanatory variables related to the risk of EHG before performing the logistic models. Variables that showed no linearity were categorized by means of the Robert method. 18 Moreover, all possible plausible interactions among variables were tested. Results were expressed as adjusted odds ratio with corresponding 95% confidence intervals.
Results
From the total series of 266 patients, 183 patients were included in the study. Early ICH growth occurred in 54 patients (29.5%), in 15 (22.3%) of 67 patients with baseline ICH Ͻ20 mL, and in 39 (33.6%) of 116 patients with baseline ICH Ն20 mL. The frequency of EHG in the total series was similar (26.9%), and there were no statistical differences in epidemiological, clinical, radiological, or analytical data between the general population and the target population (data not shown).
Potential predictors of EHG in the bivariate analysis are shown in Table 1 . Age, gender, frequency of risk factors, time from symptoms onset to admission, CSS score, body temperature, and blood pressure were similar in both groups. Patients with EHG had larger volume of peripheral hypodensity, higher leukocyte count and plasma fibrinogen levels at admission, and lower platelet count and intraventricular bleeding than did non-EHG patients.
Plasma concentrations of IL-6, TNF-␣, MMP-9, and c-Fn were significantly higher in patients with subsequent EHG (Table 2) . Similar results were found when EHG was defined according to the Ͼ33% growth definition for all patients. Concentrations of these molecules by the percentage of change in the ICH volume at 48 hours are shown in the Figure. A highly significant correlation was found between plasma c-Fn and MMP-9 levels on admission and the percentage of ICH growth (rϭ0.77 and rϭ0.64, respectively; both PϽ0.001). Also, a significant moderate correlation was found between baseline TNF-␣ and IL-6 levels and the percentage of ICH growth (rϭ0.26 and rϭ0.32, respectively; both PϽ0.001).
Because of lack of linearity, IL-6, TNF-␣, MMP-9, and c-Fn were classified in 2 categories. Of all these variables associated with EHG in bivariate analyses, plasma c-Fn levels Ͼ6 m/mL and IL-6 levels Ͼ24 pg/m were associated with increased risk of EHG in the final logistic model, whereas intraventricular bleeding was associated with a decreased risk ( Table 3) . No interactions were found. c-Fn Ͼ6 m/mL (OR, 297; 95% CI, 28 to 3128) was the only predictive factor of EHG according to the Ͼ33% growth definition for all patients.
Follow-up at 90 days was completed in 53 patients with EHG and in 123 without EHG. EHG was significantly associated with an increased risk of END (OR, 3.7; 95% CI, 1.1 to 12.4), mortality (OR, 5.2; 95% CI, 1.9 to 14.2), and poor functional outcome at 3 months (OR, 3.7; 95% CI, 1.0 to 13.2) after adjustment for potential confounders in the bivariate analysis (data not shown).
Discussion
The knowledge of the underlying mechanisms and factors associated with EHG is crucial because they represent potential targets for therapeutic interventions. In the only previous prospective study, Brott et al failed to reveal any clinical, radiological, or analytic predictor of ICH growth. 2 The present study has demonstrated that high plasma levels of c-Fn and IL-6 at baseline are independent predictors of ICH enlargement. These findings support the idea that some molecular signatures in blood of endothelial damage and inflammatory response may help to predict patients with a high risk of subsequent EHG. This fact is clinically relevant, because this study has confirmed that ICH growth is associated with a 3.7-fold increase in the odds of early neurological deterioration and poor functional outcome, and a 5.2-fold increase in the odds of mortality at 3 months.
The present results are consistent with the pathophysiology of brain edema and secondary neuronal injury in ICH. After the initial arterial rupture, the activation of the coagulation cascade produces a large quantity of thrombin that is implicated in several functions, including chemotaxis of leukocytes, expression of adhesion molecules, release of inflammatory cytokines, blood-brain barrier disruption, and local metalloproteinase generation. 7, 19 Furthermore, the release of iron after erythrocyte lysis may contribute to blood-brain barrier dysfunction, possibly through a free radical-mediated damage of endothelial wall. 20 Although all these mechanisms seem to be involved in edema formation after ICH, 9,10 their role in the EHG remains unclear. Taken together, our findings suggest a greater acute inflammatory response in patients with subsequent ICH enlargement. 21, 22 Higher number of leukocytes and levels of fibrinogen, IL-6, and TNF-␣ in the peripheral blood were found in patients with EHG, in whom we also found a greater volume of peripheral edema at baseline. Notably, IL-6 levels Ͼ24 pg/mL increased 16-fold the risk of EHG after controlling for other markers of inflammation. Intraventricular bleeding appeared to be a protective factor for ICH growth but presumably was caused by the extravasation of blood into the ventricular system. The relationship between an increased inflammatory reaction and EHG might be caused by the disappearance of the basal lamina components, such as c-Fn, laminin, and collagen IV, and by the loss of microvascular integrity in the tissue around the hematoma caused by the activation of matrix metalloproteinases. 6, [23] [24] [25] [26] In this context, both MMP-9 and c-Fn concentrations in blood were significantly higher in patients with EHG, and c-Fn was the most powerful predictor of ICH enlargement. Plasma c-Fn levels Ͼ6 g/mL were associated with 92-fold increase in the risk of EHG, and c-Fn levels showed a high correlation with the percentage of the ICH growth. Because c-Fn is largely confined to the vascular endothelium, 27 high plasma levels of this molecule might be indicative of endothelial damage. In fact, plasma c-Fn levels have been reported to be increased in patients with vascular injury secondary to vasculitis, sepsis, acute major trauma, and diabetes, and in patients with ischemic stroke. 28, 29 In addition, c-Fn plays an important role in blood clot formation by mediating the adhesion of platelets to fibrin, 30 so the disappearance of the c-Fn of the vascular endothelium might damage this clotting mechanism, facilitating ICH enlargement. However, the synthesis of c-Fn may be triggered during inflammatory processes by agents such as transforming growth factors and leukocytes. 31, 32 This study has a number of limitations. First, this is a secondary study in patients selected from a larger series of ICH studied with the aim to investigate factors associated with neurological deterioration. However, we can reasonably rule out a selection bias because baseline characteristics and the frequency of ICH growth were similar in the original and target populations. Second, because of exclusion criteria, our findings cannot be generalized to patients in coma at admission or who die within the first 48 hours after admission. Finally, an increase of the molecular markers as a result of an acute phase reaction or previous systemic diseases cannot be completely ruled out. However, a direct relationship is likely because increased c-Fn and IL-6 levels were detected at admission before EHG in patients in whom radiological findings, biochemical parameters, and vital signs evaluated at the moment the blood samples were drawn were not different from those in patients in whom a relevant ICH growth did not develop, so we cannot attribute the differences in these markers to a different acute-phase response or to a distinct previous comorbidity.
In conclusion, the present study demonstrates that molecular signatures in blood of inflammatory response and endothelial basal lamina disruption within the first 12 hours of ICH are important predictors of subsequent EHG. These findings may open new therapeutic strategies for the treatment of ICH. 
